Continuative vs Sequential Phototherapy in Non-segmental Vitiligo Patients
Phase 3
18 Years
60 Years
18 Years
60 Years
Open (Enrolling)
Both
Vitiligo
Both
Vitiligo
Trial Information
Continuative vs Sequential Phototherapy in Non-segmental Vitiligo Patients
Inclusion Criteria:
- Aged between 18 and 60 years old
Exclusion Criteria:
- Phototype I
- Previous treatment with any kind of phototherapy in the last 6 months.
- Patients with counter indications for PUVA or phototherapy (history of skin cancer,
pregnancy, etc.).
- Acral vitiligo (only hands and feet are affected).
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
The percentage of repigmentation on the target lesions will be evaluated at the end of each treatment in both groups.
Outcome Time Frame:
6 months
Safety Issue:
No
Principal Investigator
Mauro Picardo, MD
Investigator Role:
Study Chair
Investigator Affiliation:
Istituto San Gallicano - Rome - Italy
Authority:
Italy: Ethics Committee
Study ID:
VETF01
NCT ID:
NCT00525395
Start Date:
April 2007
Completion Date:
June 2011
Related Keywords:
- Vitiligo
- Phototherapy
- Vitiligo scoring system
- Vitiligo
Name | Location |
|---|
